Over
Dr Savage trained in Medicine in Bristol. Dr Savage also trained in Medical Oncology at the Royal Marsden and Imperial Hospitals. Dr Savage was a Consultant at Charing Cross Hospital for ten years, where they were clinical lead for testicular cancer, urology oncology, chemotherapy and acute oncology. Following a career sabbatical with the BCCA in Canada, they returned to the UK to practice. Dr Savage has a strong research interest and has over 150 medical and scientific publications. Alongside this, they have extensive experience in clinical care of patients with urological malignancies.
Dr Savage trained in Medical Oncology at the Royal Marsden and Imperial Hospitals and was for many years a Consultant at Charing Cross Hospital in London where they were the lead clinician for chemotherapy and urology oncology. Following a career break in Vancouver Island, Canada, working for the British Columbia Cancer Agency, Dr Savage returned to the UK. Dr Savage has a specialist interest in the management of urology malignancies and also in rare malignancies.
Dr Savage obtained a PhD in the immunotherapy of cancer and has retained an ongoing activity in this area. They have worked closely with a number of biotechnology and pharmaceutical companies on both immunotherapy and cancer gene therapy projects. More recently, Dr Savage has worked on a new approach to chemotherapy sensitivity and resistance of cancer cells and exploring the potential for novel approaches to therapy. Alongside these laboratory-based projects, Dr Savage has also published several papers looking at clinical research predominantly in gynaecology oncology and uro-oncology.
Dr Savage trained in Medical Oncology at the Royal Marsden and Imperial Hospitals and was for many years a Consultant at Charing Cross Hospital in London where they were the lead clinician for chemotherapy and urology oncology. Following a career break in Vancouver Island, Canada, working for the British Columbia Cancer Agency, Dr Savage returned to the UK. Dr Savage has a specialist interest in the management of urology malignancies and also in rare malignancies.
Dr Savage obtained a PhD in the immunotherapy of cancer and has retained an ongoing activity in this area. They have worked closely with a number of biotechnology and pharmaceutical companies on both immunotherapy and cancer gene therapy projects. More recently, Dr Savage has worked on a new approach to chemotherapy sensitivity and resistance of cancer cells and exploring the potential for novel approaches to therapy. Alongside these laboratory-based projects, Dr Savage has also published several papers looking at clinical research predominantly in gynaecology oncology and uro-oncology.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Philip Savage
Opleiding & training
-
2013–2019 MD · Medicine and Surgery
-
2019–2023 Residency · Oncologie
-
2023–2024 Fellowship · Subspecialty training
Carrière & aanstellingen
-
2023-09–2024-08 Junior consultant
Vergunningen & verzekering
Medische licenties
GB — Organización Médica Colegial de España (OMC)
Boardcertificeringen
European Board of Oncologie
Beroepsaansprakelijkheidsverzekering:
AmTrust Europe · 5,000,000 EUR dekking · No claims on file
Uitgevoerde procedures
| Procedure | Code | Levenslang aantal |
|---|---|---|
| GP consultation | 99213 | 745 |
| Annual physical exam | 99395 | 2,919 |
| Vaccination administration | 90471 | 2,359 |
| Minor procedure (skin) | 17110 | 368 |
Diensten & prijzen
| Dienst | Duur | Modaliteit | Prijs |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 810.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 540.00 EUR |
Praktijk, team & in praktijk
Video's
Onderzoek & publicaties
h-index: 21 · i10: 10
-
European registry analysis of Oncologie outcomes
DOI: 10.1411/euroclin.2025.0 · PMID: 32436449 · geciteerd door 137
-
Outcomes of Oncologie in adults — a multi-centre cohort
DOI: 10.4786/euroclin.2024.1 · PMID: 37082009 · geciteerd door 115
-
European registry analysis of Oncologie outcomes
DOI: 10.9267/euroclin.2023.2 · PMID: 31428530 · geciteerd door 93
-
Outcomes of Oncologie in adults — a multi-centre cohort
DOI: 10.4589/euroclin.2022.3 · PMID: 33605931 · geciteerd door 127
Uitgenodigde lezingen
- Practical updates in Oncologie European Annual Congress (Oncologie) · Vienna · 2024 · invited
- Single-centre experience in Oncologie National Society Meeting · London · 2023 · oral abstract
Onderscheidingen & lidmaatschappen
Onderscheidingen
- 🏆 Top-rated Oncologie — London · EuroClinics Patient Choice · 2025 · regional
Lidmaatschappen
- WONCA Europe — Family Doctors — Member · Sinds 2024
- national college of family doctors — Member · Sinds 2024
- European Union of Medical Specialists (UEMS) — Member · Sinds 2024
Artikelen van deze arts
- Patient education Patient guide to Oncologie
- Awareness When should you see a oncologie?
Voor internationale patiënten
- Coördinator
- Patient liaison · dr.philip.savage@euroclinics.example
Locatie
1 tagPatiëntbeoordelingen
Deel uw ervaring — help andere patiënten de juiste arts te vinden. Schrijf een recensie →
Recente recensies
-
★★★★★ ✓ Geverifieerd Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Geverifieerd Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Geverifieerd Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
Vergelijkbare specialisten
Alles bladeren →
Mr Abdulla Alhasso
Oncologie · Glasgow
Dr Alexander McDonald
Oncologie · Glasgow
Dr Amna Sheri
Oncologie · London
Dr Angus Robinson
Oncologie · Horley
Dr Anne Armstrong
Oncologie · Manchester
Dr Ashraf Azzabi
Oncologie · Washington
Dr Clare Green
Oncologie · Winchester
Dr Desmond Yip
Oncologie · Garran